mobile header
telelphone
Home > Doctors > Dr Pradeep Thapa
Dr Pradeep Thapa

Dr Pradeep Thapa american Oncology Hospitals

Dr Pradeep Thapa

Nuclear Medicine

Book an Appointment
Share Profile share

Dr Pradeep Thapa is associated with American Oncology Institute, Gurugram as a Senior Consultant, Nuclear Medicine.

He has an extensive work experience of 12 years+ in the field of Nuclear Medicine & has an expertise in the diagnostic & therapeutic applications of Nuclear Medicine.

Dr Pradeep has obtained his training with some of the best institutes in the country. He graduated from the prestigious T.N. Medical College, Mumbai, followed by Diploma in Radiation Medicine from Institute of Nuclear Medicine and Allied Sciences, Delhi University. He further pursued his D.N.B. from Radiation Medicine Centre, Mumbai, followed by Fellowship from European Board of Nuclear Medicine (FEBNM).

Dr Pradeep has published many research papers in some of the renowned medical journals. He has also participated in many national & international medical conferences & presented papers at various forums in the field of Nuclear Medicine.

  • MBBS from TN Medical College, Mumbai Central, Mumbai -2007
  • DRM from Institute of Nuclear Medicine and Allied Sciences, Delhi University - 2010- 2012
  • DNB Nuclear medicine, Radiation Medicine Centre, Mumbai - 2013-2015
  • Fellow European Board of Nuclear Medicine (FEBNM) - October 2018

Dr Thapa has worked extensively on PET CT, SPECT-CT & Gamma Camera system, with experience in managing patients with thyroid disorders including radio-iodine therapy treatment. Reading and interpretation of PET CT, Gamma camera, SPECT CT scan, including new PET tracers Ga-68 DOTANOC and Ga-68 PSMA.

Also has an experience in administrating radionuclides for Nuclear Medicine Therapy using Lutetium DOTANOC for Neuroendocrine tumours, I-131 for Carcinoma Thyroid, Sm-153 EDTMP and Lu-177 EDTMP for bone pain palliation and Iodine 131 MIBG for Metastatic Inoperable Neuroblastomas, Paraganglioma, Carcinoid Tumours and Pheochromocytomas & Lutetium 177 PSMA for Metastatic Prostate Cancer.

  • Consultant (Nuclear Medicine) - Basavatarakam Indo-American Cancer Hospital & Research Institute, Hyderabad, Telangana - December, 2022 to May,2024
  • Consultant (Nuclear Medicine), Venkateshwar Hospital, Dwarka, New Delhi - June 2016 – December 2022
  • Consultant in (Nuclear Medicine), Vijaya Diagnostic Centre, Hyderabad, Telangana - August 2015 – June 2016
  • Fellowship in PET-CT in Nuclear Medicine - Department, Medanta Hospital, Gurgaon, Haryana - July 2015 – August 2015
  • Senior Resident in the Department of Nuclear Medicine, Safdarjung Hospital, New Delhi - June 2012 – February 2013
  • Thapa P, Basu S. Leveraging the power of non-radium radionuclide treatments in bone metastases. Q J Nucl Med Mol Imaging. 2019 Jul 1.
  • Basu S, Chakraborty S, Parghane RV, Kamaldeep, Ranade R, Thapa P. One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [ 177 Lu] Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian setting. Am J Nucl Med Mol Imaging. 2020 Aug 25;10(4):178-211.
  • Thapa P, Kalshetty A, Basu S. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary: A subgroup-specific analysis based on clinical presentation. World J Nucl Med. 17(4):219-222. Oct-Dec 2017.
  • Dutta D, Pandey RK, Gogoi R, Solanki N, Madan R, Mondal A, Dogra S, Thapa P. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes. Endokrynol Pol. 69(2):205-210. 2018.
  • Thapa P, Parghane R, Basu S. 177-Lu DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites. World J Nucl Med. 16(3):223-228. Jul-Sep 2017.
  • Recipient of Alavi-Mandell Award for publication titled “Clinical efficacy and safety comparison of 177Lu-EDTMP with 153Sm-EDTMP on an equidose basis in patients with painful skeletal metastases”.
  • Best poster recipient for “Comparative study between Tc-99m Methionine and C-11 Methionine in detection of recurrence in primary brain tumor” at Annual Conference of Society of Nuclear Medicine, India, 2011.

DMC 42191

  • Member of European Association of Nuclear Medicine.
  • Member of Society of Nuclear Medicine, India.
  • English
  • Hindi